Divergent populations of HIV-infected naive and memory CD4+ T cell clones in children on antiretroviral therapy
BACKGROUNDNaive cells comprise 90% of the CD4+ T cell population in neonates and exhibit distinct age-specific capacities for proliferation and activation. We hypothesized that HIV-infected naive CD4+ T cell populations in children on long-term antiretroviral therapy (ART) would thus be distinct from infected memory cells.METHODSPeripheral blood naive and memory CD4+ T cells from 8 children with perinatal HIV on ART initiated at age 1.7-17 months were isolated by FACS. DNA was extracted from sorted cells, and HIV proviruses were counted, evaluated for intactness, and subjected to integration site analysis (ISA).RESULTSNaive CD4+ T cells containing HIV proviruses were detected in children with 95% statistical confidence. A median 4.7% of long terminal repeat-containing naive CD4+ T cells also contained HIV genetic elements consistent with intactness. Full-length proviral sequencing confirmed intactness of 1 provirus. In the participant with the greatest degree of naive cell infection, ISA revealed infected expanded cell clones in both naive and memory T cells, with no common HIV integration sites detected between subsets. Divergent integration site profiles reflected differential gene expression patterns of naive and memory T cells.CONCLUSIONThese results demonstrate that HIV persisted in both naive and memory CD4+ T cells that underwent clonal expansion and harbored intact proviruses, and suggest that infected memory T cell clones do not frequently arise from naive cell differentiation in children with perinatal HIV on long-term ART.FUNDINGCenter for Cancer Research, NCI; Office of AIDS Research; NCI FLEX; Children's and Emory Junior Faculty Focused Award.
Authors
- Xiaolin Wu (ORCID: https://orcid.org/0000-0002-6432-1300)
- Mary F. Kearney (ORCID: https://orcid.org/0000-0003-3839-6576)
- Anna M. Horner
- Victoria Neer
- Maud Mavigner (ORCID: https://orcid.org/0000-0001-9898-317X)
- Jason W. Rausch (ORCID: https://orcid.org/0000-0002-8377-425X)
- Sean C. Patro (ORCID: https://orcid.org/0000-0001-7550-6047)
- Shuang Guo (ORCID: https://orcid.org/0000-0002-6837-7125)
- Adam A. Capoferri (ORCID: https://orcid.org/0000-0002-6048-2115)
- Mary Grace Katusiime (ORCID: https://orcid.org/0000-0002-0468-0600)
- Ann Chahroudi (ORCID: https://orcid.org/0000-0001-7479-9546)
- Brian T. Luke (ORCID: https://orcid.org/0000-0002-2777-7376)
- Wenjie Wang (ORCID: https://orcid.org/0000-0003-2067-1250)
Institutions
- Leidos (United States) (US)
- Emory University (US)
- Cancer Research Horizons (GB)
- Frederick National Laboratory for Cancer Research (US)
- Center for Cancer Research (US)
Publication Details
- Journal
- Journal of Clinical Investigation
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1172/jci188533
- Citations
- 5
- Primary Topic
- HIV Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.18